Discover the latest market movers making waves in premarket trading!
Sunrun: Despite a recent downgrade by RBC Capital Markets, the firm’s shares only dipped slightly by nearly 2%. This comes after Sunrun faced its largest one-day loss in history during a solar sector sell-off.
CERo Therapeutics Holdings: This immunotherapy powerhouse saw its stock pull back by about 28%. Earlier, it had surged by over 188% after the FDA granted its acute myeloid leukemia drug CER-1236 orphan drug status.
Chemours: The chemical giant experienced a modest 1% decrease following a second-quarter forecast that fell short of Wall Street expectations. The revised outlook predicts a consolidated adjusted EBITDA between $215 million and $225 million.
Regencell Bioscience: After an extraordinary rise, this company saw a 13% decline. Regencell’s stock exploded earlier in the week due to a massive 38-for-1 stock split and its claims of treating ADHD and autism with traditional Chinese herbal remedies.
Oracle: The tech leader saw a 1% boost following Guggenheim’s decision to raise its price target to the highest on Wall Street. Analyst John DiFucci notes that Oracle stands on the brink of a significant narrative shift catalyzed by decades of tech innovation.
Zoetis: This animal health titan’s shares slipped by 1% after a Stifel downgrade. The firm anticipates a slowdown in Zoetis’ revenue growth amid intensifying competition.
Korn Ferry: The consulting firm’s shares rose by about 10% following stellar fourth-quarter results that exceeded analyst expectations both in terms of earnings and revenue.
Circle Internet Group: The company, known for its stablecoin USDC, saw a 3% stock rise as the U.S. Senate passed the groundbreaking GENIUS bill, creating federal guidelines for digital dollars aligned with the U.S. dollar.
Stay informed and watch these companies as they continue to shape the market landscape!
The post PRISM Stocks making the biggest moves premarket: Sunrun, Korn Ferry, Oracle, Circle and more appeared first on PRISM MarketView.
